GSK plc - Dec 7, 2023 Form 4 Insider Report for Wave Life Sciences Ltd. (WVE)

Role
10%+ Owner
Signature
/s/ Victoria Whyte, Authorized Signatory, GSK plc
Stock symbol
WVE
Transactions as of
Dec 7, 2023
Transactions value $
$16,500,000
Form type
4
Date filed
1/30/2024, 04:39 PM
Previous filing
Jan 30, 2023
Next filing
Oct 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WVE Ordinary Shares Purchase $16.5M +3.3M +30.89% $5.00 14M Dec 7, 2023 By Corporation F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares reported herein are held of record by Glaxo Group Limited, a wholly-owned subsidiary of GSK plc (the "Reporting Person").